Novavax Inc (NVAX)

1.16
0.04 2.90
NASDAQ : Health Care
Prev Close 1.19
Open 1.20
Day Low/High 1.13 / 1.21
52 Wk Low/High 4.08 / 15.01
Volume 3.12M
Avg Volume 6.36M
Exchange NASDAQ
Shares Outstanding 282.61M
Market Cap 327.83M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Trade More Firmly in the Green After Comey's Prepared Testimony Is Released

Stocks Trade More Firmly in the Green After Comey's Prepared Testimony Is Released

Stocks wade further into the green on Wednesday afternoon after former FBI director James Comey's prepared testimony is made public.

Midday Report: Crude Stockpiles Rise for First Week in Nine; Stocks Rise

Midday Report: Crude Stockpiles Rise for First Week in Nine; Stocks Rise

Stocks move cautiously higher as investors wait for direction from a number of market-churning events tomorrow.

Crude Oil Limits Gains on Wall Street After Surprise Rise in Stockpiles

Crude Oil Limits Gains on Wall Street After Surprise Rise in Stockpiles

Stocks move cautiously higher on Wednesday as investors wait for direction from a number of market-churning events on Thursday and a major selloff in crude kneecaps indexes.

Stock Futures Little Changed as Wall Street Looks to Thursday's Events

Stock Futures Little Changed as Wall Street Looks to Thursday's Events

Stock futures are in a holding pattern again on Wednesday as investors cautiously wait for direction from a number of market-churning events on Thursday.

Novavax RSV F Vaccine Phase 2 Clinical Trial Data In Women Of Child Bearing Age Published In Vaccine

Trial demonstrated a reduction of RSV infection in vaccinated women of greater than 50%, suggesting potential benefits to the mother, pregnancy outcomes and her infant

Biotech Movers: Akebia, Editas, Novavax

Biotech Movers: Akebia, Editas, Novavax

Akebia Therapeutics, Editas Medicine and Novavax were among the biotech movers in premarket trading on Tuesday.

Biotech Movers Trading Positive Ahead of Market's Open

Biotech Movers Trading Positive Ahead of Market's Open

Intellia Therapeutics led the movers.

Biotech Movers: Sarepta, Bellicum, Novavax

Biotech Movers: Sarepta, Bellicum, Novavax

Sarepta Therapeutics, Bellicum Pharmaceuticals and Novavax were among the biotech stock movers in premarket trading on Wednesday.

These 5 Stocks Under $10 Could Ignite Soon

These 5 Stocks Under $10 Could Ignite Soon

Here's a technical look at how to trade several under-$10 stocks that could break out soon.

Biotech Premarket Movers: Cempra, Novavax, Ionis

Biotech Premarket Movers: Cempra, Novavax, Ionis

Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

Sage Therapeutics Leads Biotech Movers on False Takeout Rumors

In addition to Sage Therapeutics, also moving biotech Friday: Novavax, Cytokinetics and Acadia Pharmaceuticals.

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.

5 Stocks Setting Up for Big Breakouts

5 Stocks Setting Up for Big Breakouts

Here's how to rake in the gains.

Commit To Purchase Novavax At $1, Earn 25% Using Options

Commit To Purchase Novavax At $1, Earn 25% Using Options

Investors eyeing a purchase of Novavax, Inc. stock, but tentative about paying the going market price of $1.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.

UPDATE -- Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

UPDATE -- Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Financial results conference call will include Investor and Analyst webcast presentation

Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Novavax To Host Conference Call To Discuss Third Quarter Financial Results On November 9, 2016

Financial results conference call will include Investor and Analyst webcast presentation